Capecitabine in Combination With Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer, a Phase II Trial
Phase of Trial: Phase II
Latest Information Update: 19 Nov 2018
Price : $35 *
At a glance
- Drugs Bendamustine (Primary) ; Capecitabine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms MBC-6
- 21 Mar 2018 Status changed from active, no longer recruiting to completed.
- 17 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 17 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.